Get started
Author

Jenysbel de la Caridad Hernández

Observed names: Jenysbel de la C. Hernández, Jenysbel de la Caridad Hernandez, Jenysbel de la Caridad Hernandez Reyes
ORCID: 0009-0002-8397-7935
Observed ORCID: 0009-0002-8397-7935
OpenAlex ID: A5043125351
Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy
2022 · Gisela María Suárez, Mauricio Catalá, et al. · Frontiers in Oncology · 9
PDF
Multivariate analysis of immunosenescence data in healthy humans and diverse diseases
2025 · Ana Laura Añé-Kourí, Jorge Luis Palomino, et al. · Frontiers in Aging · 3
PDF
Assessment of non-classical lymphocyte populations in patients with advanced lung cancer treated with Biomodulina T following platinum-based chemotherapy
2024 · Gisela María Suárez, Mauricio Catalá, et al. · Exploration of Immunology · 1
PDF
Targeting CD6 in solid tumors: safety, early efficacy, and mechanistic insights from a proof-of-concept trial of itolizumab
2026 · Cynthia González Muñoz, Raiza Ruiz-Lorente, et al. · Journal for ImmunoTherapy of Cancer
PDF
Immune Response in Patients Diagnosed with Non-Muscle Invasive Bladder Cancer Treated with CIMAvax-EGF Concomitant with Intravesical Bacillus Calmette-Guerin
2020 · Jenysbel de la Caridad Hernández, Laura Martínez, et al. · Journal of Cancer Science and Clinical Therapeutics
Works count: 5
Citation count: 13
H-index: 2
I10-index:
Year
Topic
Type